Sort by

Send to

Choose Destination

Links from PubMed

Items: 3


Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma.

Rosenberg SA, Yang JC, Schwartzentruber DJ, Hwu P, Marincola FM, Topalian SL, Restifo NP, Dudley ME, Schwarz SL, Spiess PJ, Wunderlich JR, Parkhurst MR, Kawakami Y, Seipp CA, Einhorn JH, White DE.

Nat Med. 1998 Mar;4(3):321-7.


The use of HLA class I tetramers to design a vaccination strategy for melanoma patients.

Palmowski M, Salio M, Dunbar RP, Cerundolo V.

Immunol Rev. 2002 Oct;188:155-63. Review.


Developing recombinant and synthetic vaccines for the treatment of melanoma.

Restifo NP, Rosenberg SA.

Curr Opin Oncol. 1999 Jan;11(1):50-7. Review.

Supplemental Content

Support Center